Heier Jeffrey S. 4
4 · OCULAR THERAPEUTIX, INC · Filed May 28, 2026
Research Summary
AI-generated summary of this filing
Ocular Therapeutix (OCUL) CSO Jeffrey Heier Sells Shares
What Happened
Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, sold 3,018 shares of company common stock in an open-market disposition on May 26, 2026. The weighted-average price was $8.20 per share for total proceeds of about $24,748. This sale was a sell-to-cover tied to RSU tax withholding and was not a discretionary trade by the reporting person.
Key Details
- Transaction date: 2026-05-26 (reported on Form 4 filed 2026-05-28). Filing appears timely.
- Price: weighted average $8.20; individual sale prices ranged $8.1529–$8.2509.
- Shares sold: 3,018; proceeds ≈ $24,748.
- Reason/footnote: Sold pursuant to a durable automatic sale instruction (adopted Apr 9, 2024) to effect a sell-to-cover election for tax withholding tied to RSUs that vested May 22, 2026. The filing states these sales were not discretionary.
- Additional note: The filer will provide a breakdown of the number of shares sold at each price on request (per the footnote).
- Shares owned after the transaction: not specified in the information provided.
Context
This was a routine, non-discretionary sell-to-cover to satisfy tax withholding on vested restricted stock units—not an indicated investment view. Such transactions are common when RSUs vest and do not necessarily signal insider sentiment about the company's prospects.
Insider Transaction Report
Form 4
Heier Jeffrey S.
Chief Scientific Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-05-26$8.20/sh−3,018$24,748→ 320,350 total
Footnotes (2)
- [F1]Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on April 9, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.1529 to $8.2509, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Signature
/s/ Todd Anderman, Attorney-in-Fact for Jeffrey S. Heier|2026-05-28